Skip to main content
77°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about AZN
Recent news which mentions AZN
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11
November 10, 2022
Tickers
AAPL
AZN
BA
COP
Tags
News
$BTC
COP
From
Benzinga
Apple Hires Facebook Veteran as Information Chief; More Departures Likely
November 10, 2022
Tickers
AAPL
AZN
CRM
META
Tags
Media
AAPL
CRM
From
Benzinga
Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks
November 10, 2022
Tickers
AZN
KO
Tags
KO
AZN
Market News
From
Motley Fool
AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength
November 10, 2022
Tickers
AZN
AZNCF
Tags
AZN
Benzinga
Biotech
From
Benzinga
AstraZeneca lifts guidance after forecast-beating profit and sales
November 10, 2022
Tickers
AZN
Tags
AZN
UK:AZN
From
MarketWatch
'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target
November 09, 2022
Tickers
AZN
EBS
JNJ
Tags
Briefs
News
Guidance
From
Benzinga
FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids
November 09, 2022
Tickers
AZN
AZNCF
Tags
FDA
AZNCF
Market News
From
Benzinga
Options Traders Expect AstraZeneca Shares To Fall After Earnings Report, As Stock Is Up 5% In 2022
November 09, 2022
Tickers
AZN
Tags
Markets
Michael Khouw
Short Ideas
From
Benzinga
Why Are Apellis Pharmaceuticals Shares Falling Today?
November 04, 2022
Tickers
APLS
AZN
Tags
Market News
FDA
Health Care
From
Benzinga
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
November 04, 2022
Tickers
AZN
AZNCF
BIOVF
SNY
Tags
BIOVF
AZN
Eurasia
From
Benzinga
Why Horizon Therapeutics' Shares Rose 11.32% on Wednesday
November 02, 2022
Tickers
AZN
HZNP
Tags
HZNP
Recent Press Releases
Market News
From
Motley Fool
Sorrento Has Potential To Deliver Multiple Best-In-Class Products
November 02, 2022
Tickers
AZN
SRNE
Tags
Initiation
Market News
Analyst Ratings
From
Benzinga
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
November 01, 2022
Tickers
AZN
DUOL
FIZZ
JNJ
Tags
BTC/USD
DUOL
MARA
From
InvestorPlace
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
Tickers
APLS
ARDX
AZN
FOLD
Tags
MGNX
Benzinga
Health Care
From
Benzinga
Hospitalizations on the rise in New York City as new COVID strains spread rapidly
November 01, 2022
Tickers
AAPL
AZN
PFE
Tags
AAPL
AZN
TW:2317
From
MarketWatch
European Regulator Grants Complete Approval To AstraZeneca's COVID-19 Vaccine
November 01, 2022
Tickers
AZN
AZNCF
Tags
Health Care
Biotech
Benzinga
From
Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
October 28, 2022
Tickers
ACB
AZN
CMPS
CYBN
Tags
ACB
News
ENVB
From
Benzinga
Why Invitae Stock Was So Healthy This Week
October 28, 2022
Tickers
AZN
NVTA
Tags
AZN
NVTA
Market News
From
Motley Fool
Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest
October 28, 2022
Tickers
AZN
BNGO
ENPH
ESLT
Tags
NOW
MSFT
ON
From
InvestorPlace
3 Perfect Stocks Retirees Can Buy Hand Over Fist Right Now
October 28, 2022
Tickers
AZN
MA
VZ
Tags
VZ
Recent Press Releases
Market News
From
Motley Fool
AstraZeneca's Ultomiris Showed Zero Relapses In Patients With Chronic Disorder Of Brain, Spinal Cord
October 27, 2022
Tickers
AZN
AZNCF
Tags
AZN
General
Large Cap
From
Benzinga
A New BioTech Research Race Is Focused On Improving Life For MS Patients
October 27, 2022
Tickers
AZN
BNTX
JNJ
KTTA
Tags
JNJ
SIGA
KTTA
From
Benzinga
Intel's Self-Driving Tech Firm Raises Over $800M In IPO, Alphabet Misses Q3 Earnings Expectations, Lyft Cuts Price For Monthly Subscription Plan: Top Stories Wednesday, Oct. 26
October 26, 2022
Tickers
AZN
BA
CLX
DIS
Tags
Earnings
Health Care
Benzinga
From
Benzinga
AstraZeneca Touts Positive Data From Two Experimental Drugs In Breast Cancer Settings
October 26, 2022
Tickers
AZN
AZNCF
Tags
AZN
Benzinga
Biotech
From
Benzinga
AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
October 26, 2022
Tickers
AZN
Tags
UK:AZN
AZN
From
MarketWatch
Twitter Considers Crypto Wallet, Geopolitical Woes To Keep Tesla Shares Volatile, Juul Explores Possible Bailout: Top Stories Tuesday, Oct. 25
October 25, 2022
Tickers
AMZN
AZN
GE
HSBC
Tags
Biotech
TWTR
GE
From
Benzinga
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
October 25, 2022
Tickers
AMGN
AZN
IQV
JNJ
Tags
AMGN
JNJ
Market News
From
Motley Fool
AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation
October 25, 2022
Tickers
AZN
AZNCF
Tags
General
AZN
Large Cap
From
Benzinga
US Stock Futures Down; Big Tech Earnings In Focus
October 25, 2022
Tickers
AZN
GE
GM
GOOG
Tags
News
POR
Eurozone
From
Benzinga
AstraZeneca's Imfinzi Combo Scores FDA Approval For Liver Cancer
October 24, 2022
Tickers
AZN
AZNCF
Tags
News
Health Care
Benzinga
From
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.